IL-6/STAT3 as well as the IL-2/STAT5 pathway activates downstream target genes to protect tumour cells from apoptosis, increase tumour cell proliferation, cell cycle progression, invasion, and metastasis, and are involved in drug resistance [57,58]. This evidence concerns the gene IL2 and neoplasm.